Keywords: کلسترول LDL; Severe hypercholesterolaemia; LDL cholesterol; Total cholesterol; Triglycerides; Cardiovascular risk; Primary prevention; Middle-aged population;
مقالات ISI کلسترول LDL (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: کلسترول LDL; Peripheral arterial disease; Lipid-lowering therapy; LDL cholesterol; Lipid targets; Statin adherence;
Keywords: کلسترول LDL; Familial hypercholesterolaemia; Primary dyslipidemia; LDL cholesterol; Epidemiology;
Keywords: کلسترول LDL; Statin; LDL cholesterol; Cardiovascular risk; Atherosclerotic cardiovascular disease; Clinical pharmacist; Lipid treatment guideline; High-intensity statin therapy;
Keywords: کلسترول LDL; GLP-1R agonist; LDL cholesterol; Statins; Type 2 diabetes; HbA1c;
Keywords: کلسترول LDL; Sitosterolemia; LDL cholesterol; Hypercholesterolemia; ABCG5/G8 genes; Ezetimibe therapy; Xanthomas;
Keywords: کلسترول LDL; BP; blood pressure; BMI; body mass index; CVD; cardiovascular disease; CI; confidence interval; FPG; fasting plasma glucose; FDR; first-degree relatives; HbA1c; glycosylated hemoglobin; HDLC; high density lipoprotein cholesterol; HC; hip circumference; HR
Keywords: کلسترول LDL; Food supplements; Functional foods; Cholesterol; LDL cholesterol; Cardiovascular risk; Primary prevention;
Keywords: کلسترول LDL; Colesterol LDL; Modelos de cálculo de riesgo; CategorÃas de riesgo cardiovascular; Estatinas; LDL cholesterol; Risk calculation models; Cardiovascular risk categories; Statins;
Cholesterol lowering efficacy of plant stanol ester in a new type of product matrix, a chewable dietary supplement
Keywords: کلسترول LDL; Dietary supplement; Plant stanol ester; LDL cholesterol; Dietary intervention;
Keywords: کلسترول LDL; CVD; cardio vascular disease; NCD; non-nommunicable disease; MONICA; multinational MONItoring of trends and determinants in CArdiovascular disease; CHD; coronary heart disease; ACS; acute coronary syndrome; TG; triglyceride; LDL-C; low density lipoprotein
Keywords: کلسترول LDL; Asians; Body mass index; Hypertension; LDL cholesterol; Waist circumference; United States;
Keywords: کلسترول LDL; LDL cholesterol; LDL subclasses; Mean LDL particle size; HDL subclasses; Non-HDL cholesterol; Ezetimibe; Sitosterolemia; Sterols;
Keywords: کلسترول LDL; Atherosclerosis; Regression; Animal models; Emigration of macrophages; HDL; LDL cholesterol;
Keywords: کلسترول LDL; Hipercolesterolemia familiar; Enfermedad coronaria; Stents liberadores de fármacos; Colesterol LDL; Familial hypercholesterolemia; Coronary disease; Drug-eluting stents; LDL Cholesterol;
Keywords: کلسترول LDL; Familial hypercholesterolemia; LDL cholesterol; Lipids; Children; Metabolomics; Metabolic profiling; IDL; intermediate density lipoprotein; L-HDL; large high density lipoprotein; M-HDL; medium high density lipoprotein; S-HDL; small high density lipoprotei
Keywords: کلسترول LDL; HDL-C; HDL cholesterol; LDL-C; LDL cholesterol; ANCOVA; analysis of covariance; DG; diglycerides; TG; triglycerides; CE; sterol esters or cholesterol esters; DG, TG; glycerolipids; TG analysed on clinical-chemical analyzers; clinical triglycerides; TC ana
Keywords: کلسترول LDL; PPARα; peroxisome proliferator-activated receptor α; AOX; alternative oxidase; ACC; acetyl-CoA carboxylase; SREBP-1c; sterol regulatory element binding protein-1c; DGAT; diacylglycerol O-acyltransferase; ACS; acetyl-CoA synthetase; TNF-α; tumor necrosi
Keywords: کلسترول LDL; Drug interaction; Effect enhancer; Grapefruit juice; Ischemic heart disease; LDL cholesterol; Statins;
Keywords: کلسترول LDL; Alcohol; Aldehyde dehydrogenase 2 genotype; LDL cholesterol; Cardiovascular disease;
Keywords: کلسترول LDL; Intima media thickness; LDL cholesterol; Total cholesterol; Premenopausal women; T2DM patients;
Keywords: کلسترول LDL; HRR; heart rate recovery; T2DM; type 2 diabetes mellitus; GTX; graded exercise treadmill test; ANS; autonomic nervous system; BMI; body mass index; BP; blood pressure; TG; triglyceride; LDL-C; LDL cholesterol; HDL-C; HDL cholesterol; HOMA-IR; homeostatic
Keywords: کلسترول LDL; Adropin; Creatinine; Glucose; HDL cholesterol; Hemoglobin; LDL cholesterol; Insulin; Parathyroid hormone; Triglycerides; UreaAdropin; Cigarette smoking; Dyslipidemia; Gene polymorphisms; Hemodialysis; Insulin resistance; Urine output
Keywords: کلسترول LDL; Elderly; Lipid-lowering drugs; LDL cholesterol; Cardiovascular disease; Narrative review;
Keywords: کلسترول LDL; Alcohol consumption; Aldehyde dehydrogenase 2; LDL cholesterol; LDL particles; Genotype; Mendelian randomization analysis;
Keywords: کلسترول LDL; Statins; Cardiovascular risk; Primary care; LDL cholesterol; Electronic medical records;
Keywords: کلسترول LDL; Cardiovascular diseases; HDL cholesterol; Triglycerides; Non-HDL cholesterol; LDL cholesterol; Apolipoprotein B; Diabetes mellitus; Middle East;
Keywords: کلسترول LDL; Heterozygous familial hypercholesterolemia; LDL cholesterol; Cardiovascular risk; Hypercholesterolemia; Hyperlipidemia;
Keywords: کلسترول LDL; Familial hypercholesterolemia; LDL cholesterol; Electronic health record; PCSK9; Statin;
Keywords: کلسترول LDL; Low-density lipoprotein (LDL) apheresis; lupus nephritis; foam cell; cholesterol crystal; nephrotic syndrome; LDL cholesterol; systemic lupus erythematosus (SLE); proteinuria;
Keywords: کلسترول LDL; Familial hypercholesterolemia; Maternal inheritance; LDL cholesterol; Children;
Keywords: کلسترول LDL; Niacin; Type 2 diabetes; Clinical trial; Meta-analysis; CI; confidence interval; FPG; fasting plasma glucose; HDL-c; HDL cholesterol; LDL-c; LDL cholesterol; RCT; randomised control trial; T2DM; type 2 diabetes mellitus; TG; triglycerides; WMD; weighted m
Keywords: کلسترول LDL; Cardiovascular risk; Dietary portfolio; Endothelial function; LDL cholesterol; Endothelial progenitor cells; Diabetes;
Keywords: کلسترول LDL; apo; apolipoprotein; HDL; high-density lipoprotein; HNF-1α,4α; hepatocyte nuclear factor-1α,4α; LRH-1; liver receptor homolog-1; Foxa2; forkhead box A2; PAF; platelet activating factor; LXR; liver X receptor; RXR; retinoid X receptor; FXR; farnesoid X
Keywords: کلسترول LDL; Cardiovascular diseases; Atherogenic risk; LDL cholesterol; Lipoprotein(a); Lipoprotein apheresis; Saxony (Germany)
Keywords: کلسترول LDL; Bariatric surgery; Obesity; HDL; Oxidised LDL; Lipoprotein-associated phospholipase A2 (Lp-PLA2); Weight loss; apo; apolipoprotein; HDL; high-density lipoprotein; HDL-C; HDL cholesterol; LDL; low-density lipoprotein; LDL-C; LDL cholesterol; Lp-PLA2; lipop
Keywords: کلسترول LDL; LDL cholesterol; Apo B antisense; MTP inhibitors; PCSK9 inhibitors;
Keywords: کلسترول LDL; Structured lipid; Behenic acid; Essential fatty acids; Low calorie fat; Atherogenic diet; Hypocholesterolemic activity; Cholesterol; LDL cholesterol;
Keywords: کلسترول LDL; Lipid metabolism; Cholesterol; LDL; PCSK9; FCHL; FCHL; familial combined hyperlipidemia; LDLR; LDL receptor; PCSK9; proprotein convertase subtilisin kexin type 9; SREBP2; sterol regulatory element binding protein 2; LDL-C; LDL cholesterol; HDL-C; HDL chol
Keywords: کلسترول LDL; BMI; Body mass index; WC; Waist circumference; DBP; Diastolic blood pressure; SBP; Systolic blood pressure; LDL-C; LDL cholesterol; HDL-C; HDL cholesterol; TG; Triglycerides; SS; Subscapular skinfold; SIS; Suprailiac skinfold; AS; Abdominal skinfold; TS;
Keywords: کلسترول LDL; Proprotein convertase subtilisin/kexin 9; LDL receptor; LDL cholesterol; Gain-of-function mutation; PCSK9 inhibitor; Dyslipidemia;
Keywords: کلسترول LDL; Impaired fasting glucose; Dyslipidemia; Colesevelam; Niacin; LDL cholesterol; Hemoglobin A1c; Fructosamine;
Keywords: کلسترول LDL; Type 2 Diabetes; LDL cholesterol; Non HDL cholesterol; Discordance; Cardiovascular risk
Pediatric reference intervals for calculated LDL cholesterol, non-HDL cholesterol, and remnant cholesterol in the healthy CALIPER cohort
Keywords: کلسترول LDL; Reference intervals; Pediatric; CALIPER; Non-fasting lipids; LDL cholesterol; Non-HDL cholesterol; Remnant cholesterol; apoA1; apolipoprotein A1; apoB; apolipoprotein B; BMI; body mas index; CALIPER; Canadian Laboratory Initiative on Pediatric Reference I
The effects of 3-year statin therapy and the achievement of LDL cholesterol target values in familial hypercholesterolemia patients: An experience from Serbia
Keywords: کلسترول LDL; Familial hypercholesterolemia; Statin; LDL cholesterol; New onset ASCVD;
Treatment goal attainment in children with familial hypercholesterolemia: A cohort study of 302 children in Norway
Keywords: کلسترول LDL; Familial hypercholesterolemia; Children; LDL cholesterol; Lipid-lowering therapy; Genetic testing;
Lowering LDL cholesterol reduces cardiovascular risk independently of presence of inflammation
Keywords: کلسترول LDL; C-reactive protein; inflammation; LDL cholesterol; randomized trials; vascular disease;
Effects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study
Keywords: کلسترول LDL; Triglycerides; Docosahexanoic acid; Total cholesterol; Subcutaneous fat; LDL cholesterol; Insulin resistance;
LDL cholesterol was more strongly associated with percent body fat than body mass index and waist circumference in a health screening population
Keywords: کلسترول LDL; Percent body fat; Body mass index; Waist circumference; LDL cholesterol; Cardiovascular risk factors;
Posttranslational modification of proprotein convertase subtilisin/kexin type 9 is differentially regulated in response to distinct cardiometabolic treatments as revealed by targeted proteomics
Keywords: کلسترول LDL; Cardiometabolic diseases; Mass spectrometry; PCSK9; Posttranslational modifications; Quantitative proteomics; Bariatric surgery; LDL cholesterol; Triglycerides; Statin; Phosphorylation;